Prevalence and risk factors of anti-tuberculosis drug-induced hepatitis in Malaysia. - Concepedia

Concepedia

Publication | Closed Access

Prevalence and risk factors of anti-tuberculosis drug-induced hepatitis in Malaysia.

51

Citations

15

References

2008

Year

OA Marzuki, A R M Fauzi, Shymaa E. Ayoub, Kamarul Imran Musa

Abstract

The prevalence of hepatitis was 9.7 percent. The presence of HIV infection and extrapulmonary TB were significant risk factors for the development of hepatitis.

References

	Year	Citations
Evaluation of Clinical and Immunogenetic Risk Factors for the Development of Hepatotoxicity during Antituberculosis Treatment Surendra K. Sharma, Arumugam Balamurugan, Pradip Kumar Saha, American Journal of Respiratory and Critical Care Medicine ImmunologyGenetic EpidemiologyPathologyClinical Risk FactorsAntituberculosis Treatment	2002	333
USPHS Tuberculosis Short-Course Chemotherapy Trial 21: Effectiveness, Toxicity, and Acceptability Debra L. Combs Annals of Internal Medicine	1990	317
Antituberculosis Drug–induced Hepatotoxicity Jaime Ungo, Denis Jones, David Ashkin, American Journal of Respiratory and Critical Care Medicine ImmunologyHepatitis BRelative RiskPharmacotherapyAntiviral Drug	1998	288
Risk factors for hepatotoxicity from antituberculosis drugs: a case-control study. J N Pande, Sarman Singh, GC Khilnani, Thorax	1996	243
The natural history of histologically proved drug induced liver disease Guruprasad P. Aithal, Christopher P. Day Gut	1999	202
Liver injury during antituberculosis treatment: An 11-year study Martin Døssing, Jon Torgny Wilcke, Dorthe Askgaard, Tubercle and Lung Disease Hepatic DisordersHepatologyLiver InjuryLiver PhysiologyHepatitis	1996	156
Hepatic toxicity in south indian patients during treatment of tuberculosis with short-course regimens containing isoniazid, rifampicin and pyrazinamide R Parthasarathy, G Raghupati Sarma, B. Janardhanam, Tubercle HepatologySouth Indian PatientsMedicineTuberculosis PreventionTuberculosis	1986	150
Hepatotoxicity of tuberculosis chemotherapy under general programme conditions in Singapore. Monica Delia Teleman, Cynthia Bin Eng Chee, Arul Earnest, PubMed	2002	111
Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis. C Grönhagen-Riska, P.-E. Hellström, B Fröseth PubMed Hepatic DisordersHepatologyIsoniazid-rifampin TreatmentViral HepatitisLiver Physiology	1978	110
A prospective clinical study of isoniazid‐rifampicin‐pyrazinamide‐induced liver injury in an area endemic for hepatitis B Shinn‐Jang Hwang, JAW‐CHING WU, CHUN‐NIN LEE, Journal of Gastroenterology and Hepatology	1997	87

Page 1